Caris Life Sciences and Xencor Enter Target Discovery Collaboration and License Agreement for Novel XmAb® Bispecific Antibodies
This document is hosted externally.
Unless the owner has removed it from the web, you can access the full document via its original URL:
https://investors.xencor.com/node/13226/pdfUnless the owner has removed it from the web, you can access the full document via its original URL:
See similar contracts (1)
Alternatively, you can try searching for similar contracts:
